Compounding pharmacies dealt blow in semaglutide shortage casenews2025-04-25T17:59:29+00:00April 25th, 2025|Endpoints News|
RFK Jr. touts program testing ways to pay for sickle cell carenews2025-04-25T17:12:04+00:00April 25th, 2025|Endpoints News|
AbbVie Q1 earnings: Immunology still a powerhouse as Skyrizi, Rinvoq hit $5B combinednews2025-04-25T11:43:58+00:00April 25th, 2025|Endpoints News|
Merck KGaA closes in on SpringWorks deal at $3.5B price pointnews2025-04-25T10:38:28+00:00April 25th, 2025|Endpoints News|
Gilead Q1 earnings: Strong HIV business balances out low Covid and cancer drug salesnews2025-04-24T20:48:10+00:00April 24th, 2025|Endpoints News|
Merck is well-stocked on Keytruda as pharma tariffs loom, CEO saysnews2025-04-24T19:12:24+00:00April 24th, 2025|Endpoints News|
Biosimilar launch challenges remain, report findsnews2025-04-24T19:01:09+00:00April 24th, 2025|Endpoints News|
Drugmakers prepare for manageable tariff hit to business, earningsnews2025-04-24T18:28:14+00:00April 24th, 2025|Endpoints News|
Cassidy urges major reforms to 340B drug discount programnews2025-04-24T18:16:58+00:00April 24th, 2025|Endpoints News|
Halozyme launches patent fight over Merck’s injectable Keytrudanews2025-04-24T16:58:38+00:00April 24th, 2025|Endpoints News|
